Myelin basic protein-primed T cells induce nitric oxide synthase in microglial cells. Implications for multiple sclerosis (Q35956034)

11 August 2017

Myelin basic protein-primed T cells induce nitric oxide synthase in microglial cells. Implications for multiple sclerosis (English)

1 reference

11 August 2017

0 references

0 references

Subhajit Dasgupta

1

1 reference

11 August 2017

Malabendu Jana

series ordinal

2

1 reference

11 August 2017

Xiaojuan Liu

series ordinal

3

1 reference

11 August 2017

Kalipada Pahan

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

9 August 2002

1 reference

Journal of Biological Chemistry

11 August 2017

1 reference

11 August 2017

277

1 reference

11 August 2017

42

1 reference

11 August 2017

39327-39333

1 reference

Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Nitric oxide and blood-brain barrier integrity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Microglia as mediators of inflammatory and degenerative diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Nitric oxide: a neural messenger

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Interferon beta for multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Rationale for immunotherapy in multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Evidence for increased nitric oxide production in multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Suppression of arthritis by an inhibitor of nitric oxide synthase

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Reactive nitrogen intermediates in human neuropathology: an overview

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Integrins: a family of cell surface receptors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Nitric oxide as a secretory product of mammalian cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Nitric oxide: a pathogenetic factor in autoimmunity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Immunological aspects of demyelinating diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Inhibitors of protein phosphatase 1 and 2A differentially regulate the expression of inducible nitric-oxide synthase in rat astrocytes and macrophages.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Induction of nitric oxide synthase in rat C6 glioma cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Characterization of ameboid microglia isolated from developing mammalian brain.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1955480

Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro

11 July 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Nitric-oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Expression of a constitutively active form of phosphatidylinositol 3-kinase inhibits the induction of nitric oxide synthase in human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

The adhesion molecule and cytokine profile of multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111841200

Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients

21 January 2018

1 reference

12 December 2020

Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide

1 reference

12 December 2020

Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice

1 reference

12 December 2020

Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts

1 reference

12 December 2020

Identifiers

DOI

10.1074/JBC.M111841200

1 reference

11 August 2017

1 reference

11 August 2017

1 reference